HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KIT oncogene inhibition drives intratumoral macrophage M2 polarization.

Abstract
Tumor-associated macrophages (TAMs) are a major component of the cancer microenvironment. Modulation of TAMs is under intense investigation because they are thought to be nearly always of the M2 subtype, which supports tumor growth. Gastrointestinal stromal tumor (GIST) is the most common human sarcoma and typically results from an activating mutation in the KIT oncogene. Using a spontaneous mouse model of GIST and 57 freshly procured human GISTs, we discovered that TAMs displayed an M1-like phenotype and function at baseline. In both mice and humans, the KIT oncoprotein inhibitor imatinib polarized TAMs to become M2-like, a process which involved TAM interaction with apoptotic tumor cells leading to the induction of CCAAT/enhancer binding protein (C/EBP) transcription factors. In human GISTs that eventually developed resistance to imatinib, TAMs reverted to an M1-like phenotype and had a similar gene expression profile as TAMs from untreated human GISTs. Therefore, TAM polarization depends on tumor cell oncogene activity and has important implications for immunotherapeutic strategies in human cancers.
AuthorsMichael J Cavnar, Shan Zeng, Teresa S Kim, Eric C Sorenson, Lee M Ocuin, Vinod P Balachandran, Adrian M Seifert, Jonathan B Greer, Rachel Popow, Megan H Crawley, Noah A Cohen, Benjamin L Green, Ferdinand Rossi, Peter Besmer, Cristina R Antonescu, Ronald P DeMatteo
JournalThe Journal of experimental medicine (J Exp Med) Vol. 210 Issue 13 Pg. 2873-86 (Dec 16 2013) ISSN: 1540-9538 [Electronic] United States
PMID24323358 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzamides
  • CCAAT-Enhancer-Binding Proteins
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Apoptosis
  • Benzamides (chemistry)
  • CCAAT-Enhancer-Binding Proteins (metabolism)
  • Cell Proliferation
  • Female
  • Gastrointestinal Stromal Tumors (drug therapy, genetics, metabolism)
  • Humans
  • Imatinib Mesylate
  • Inflammation
  • Macrophages (immunology)
  • Male
  • Mice
  • Middle Aged
  • Mutation
  • Phenotype
  • Piperazines (chemistry)
  • Proto-Oncogene Proteins c-kit (metabolism)
  • Pyrimidines (chemistry)
  • Sarcoma (drug therapy, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: